These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5518998)

  • 1. [Combination treatment of engodenous depressions].
    Smidt E
    Nord Psykiatr Tidsskr; 1970; 24(3):228-34. PubMed ID: 5518998
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial with imipramine-N-oxide and amitriptyline-N-oxide].
    Dencker SJ
    Nord Psykiatr Tidsskr; 1971; 25(5):463-70. PubMed ID: 4947298
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences in the metabolism of norepinephrine in depressions. The effects of various therapies.
    Rosenblatt S; Chanley JD
    Arch Gen Psychiatry; 1965 Dec; 13(6):495-502. PubMed ID: 5843233
    [No Abstract]   [Full Text] [Related]  

  • 4. Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline.
    Beckmann H; Goodwin FK
    Arch Gen Psychiatry; 1975 Jan; 32(1):17-21. PubMed ID: 1089399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which tricyclic for depressed outpatients, imipramine pamoate or amitriptyline?
    Goldberg HL; Finnerty RJ
    Dis Nerv Syst; 1977 Oct; 38(10):785-9. PubMed ID: 332472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guides to appropriate drug therapy of depressed patients.
    Hordern A
    Int J Psychiatry; 1967 Apr; 3(4):304-7. PubMed ID: 6041325
    [No Abstract]   [Full Text] [Related]  

  • 7. EEC frequency analysis in the treatment with some antidepressive drugs (imipramine, amitriptyline, dibenzepine, dimethacrine).
    Misurec J
    Act Nerv Super (Praha); 1971; 13(3):218-9. PubMed ID: 5113846
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients.
    Post RM; Goodwin FK
    Arch Gen Psychiatry; 1974 Feb; 30(2):234-9. PubMed ID: 4809930
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence-possibilities on therapy-resistant late depressions.
    Walcher W
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):207-10. PubMed ID: 4614276
    [No Abstract]   [Full Text] [Related]  

  • 10. [Melitracen and imipramine in treatment of depression. A comparative study based on a controlled clinical test].
    Venäläinen E; Hakola P
    Nord Psykiatr Tidsskr; 1968; 22(5):400-7. PubMed ID: 4894432
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of antidepressants and neuroleptics in the treatment of depression.
    Simpson GM; Amin M; Angus JW; Edwards JG; Go SH; Lee JH
    Arch Gen Psychiatry; 1972 Sep; 27(3):337-45. PubMed ID: 5051622
    [No Abstract]   [Full Text] [Related]  

  • 12. Multihospital controlled comparison of the therapeutic effects of four antidepressants.
    Act Nerv Super (Praha); 1971; 13(3):166-7. PubMed ID: 4939827
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficacy of amoxapine, maprotiline, and trazodone in comparison to imipramine and amitriptyline: a review of the literature.
    Kane JM; Lieberman J
    Psychopharmacol Bull; 1984; 20(2):240-9. PubMed ID: 6374720
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy susceptibility to thymoleptics in depression].
    Smidt E
    Nord Psykiatr Tidsskr; 1972; 26(7):414-6. PubMed ID: 4652987
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of two drug treatments in depressive illness.
    Browne MW
    Br J Psychiatry; 1969 Jun; 115(523):693-6. PubMed ID: 4896804
    [No Abstract]   [Full Text] [Related]  

  • 16. The psychiatrist attitudes and therapeutic means when faced with resistant depressions.
    Ginestet D
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):194-8. PubMed ID: 4216905
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolism of norepinephrine in depressions. Differences and effects of therapies.
    Rosenblatt S; Chanley JD
    Can Psychiatr Assoc J; 1966; 11 Suppl():Suppl:50-60. PubMed ID: 5937839
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy possibilities for therapy-resistant depressions.
    Berner P; Kryspin-Exner K; Poeldinger W
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):189-93. PubMed ID: 4614274
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent vital depressions. A follow-up study of 56 female and 28 male patients.
    van Scheyen JD
    Psychiatr Neurol Neurochir; 1973; 76(2):93-112. PubMed ID: 4700934
    [No Abstract]   [Full Text] [Related]  

  • 20. Conditioning in the prediction of therapeutic outcome in depressions.
    Ban TA; Lehmann HE; Green AA
    Cond Reflex; 1969; 4(2):115-23. PubMed ID: 4390593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.